Cortendo AB, a developer of drugs for orphan endocrine disorders, has appointed A. Brian Davis as its chief financial officer. Mr Davis was previously CFO at Tengion Inc, a regenerative medicines company. He received an MBA from the Wharton School of the University of Pennsylvania. Concurrently, Cortendo appointed Stephen Long as its chief legal officer. Mr Long was most recently an attorney at the law firm of Reed Smith LLP.
Cortendo announced the appointments on 23 March 2015.
Copyright 2015 Evernow Publishing Ltd